These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 4058312)

  • 1. Postprandial distribution of apolipoproteins C-II and C-III in normal subjects and patients with mild hypertriglyceridemia: comparison of meals containing corn oil and medium-chain triglyceride oil.
    Barr SI; Kottke BA; Mao SJ
    Metabolism; 1985 Nov; 34(11):983-92. PubMed ID: 4058312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial exchange of apolipoprotein C-III between plasma lipoproteins.
    Barr SI; Kottke BA; Mao SJ
    Am J Clin Nutr; 1981 Feb; 34(2):191-8. PubMed ID: 7211723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J; Karpe F; Milne RW; Hamsten A
    J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects.
    Asakura L; Lottenberg AM; Neves MQ; Nunes VS; Rocha JC; Passarelli M; Nakandakare ER; Quintão EC
    Am J Clin Nutr; 2000 Mar; 71(3):701-5. PubMed ID: 10702162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.
    Fredenrich A; Giroux LM; Tremblay M; Krimbou L; Davignon J; Cohn JS
    J Lipid Res; 1997 Jul; 38(7):1421-32. PubMed ID: 9254067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men.
    Kashyap ML; Barnhart RL; Srivastava LS; Perisutti G; Vink P; Allen C; Hogg E; Brady D; Glueck CJ; Jackson RL
    J Lipid Res; 1982 Aug; 23(6):877-86. PubMed ID: 7130856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alimentary lipemia: plasma high-density lipoproteins and apolipoproteins CII and CIII in healthy subjects.
    Kashyap ML; Barnhart RL; Srivastava LS; Perisutti G; Allen C; Hogg E; Glueck CJ; Jackson RL
    Am J Clin Nutr; 1983 Feb; 37(2):233-43. PubMed ID: 6823885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of VLDL composition during alimentary lipemia.
    Björkegren J; Hamsten A; Milne RW; Karpe F
    J Lipid Res; 1997 Feb; 38(2):301-14. PubMed ID: 9162750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal.
    Cohn JS; McNamara JR; Cohn SD; Ordovas JM; Schaefer EJ
    J Lipid Res; 1988 Jul; 29(7):925-36. PubMed ID: 3411251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia.
    Annuzzi G; Holmquist L; Carlson LA
    Scand J Clin Lab Invest; 1989 Feb; 49(1):73-81. PubMed ID: 2727620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
    Dallinga-Thie GM; Berk-Planken II; Bootsma AH; Jansen H;
    Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia.
    Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P
    Miner Electrolyte Metab; 1999; 25(4-6):258-62. PubMed ID: 10681649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of guar gum on plasma lipoproteins and apolipoproteins C-II and C-III in patients affected by familial combined hyperlipoproteinemia.
    Bosello O; Cominacini L; Zocca I; Garbin U; Ferrari F; Davoli A
    Am J Clin Nutr; 1984 Dec; 40(6):1165-74. PubMed ID: 6095636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA; Gibson JC; Ginsberg HN
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
    Zheng C; Khoo C; Furtado J; Sacks FM
    Circulation; 2010 Apr; 121(15):1722-34. PubMed ID: 20368524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients.
    Marcoux C; Tremblay M; Nakajima K; Davignon J; Cohn JS
    J Lipid Res; 1999 Apr; 40(4):636-47. PubMed ID: 10191287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.